Skip to content

Effects of different rehabilitation modality on cardiopulmonary function in patients with acute coronary syndrome after revascularization

Exploratory study on the "three-level linkage" disease management model of acute coronary syndrome using traditional Chinese medicine + Internet based on "medical association

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081034
Enrollment
Unknown
Registered
2024-02-20
Start date
2021-03-24
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Interventions

home-based rehabilitation group:Family rehabilitation
center guided home-based rehabilitation group:center guided home-based rehabilitation

Sponsors

Beijing anzhen hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age between 35 and 70 years old; Coronary angiography confirmed ACS; More than 48 hours and less than 1 week after complete coronary revascularization; Determined treatment plan; Normal signs of myocardial injury; Stable patient's condition; No risk of sudden death caused by malignant arrhythmia.

Exclusion criteria

Exclusion criteria: New ischemic symptoms could be clearly observed by resting ECG; Uncontrolled arrhythmia leading to symptoms or hemodynamic disorders; Unstable angina pectoris; Decompensated heart failure; Active endocarditis, subacute myocarditis, or pericarditis; Acute non-cardiac diseases, such as infection, renal failure, hyperthyroidism; Acute pulmonary embolism or pulmonary infarction; Quiet heart rate > 120 beats/min (including transient increase); Incompatibility of patients; Electrolyte abnormalities; Bradycardia or tachycardia; Systolic blood pressure > 200mmHg and diastolic blood pressure>100mmHg at rest; Complicated ventricular arrhythmia; Severe valvular disease; Hypertrophic heart disease or other outflow tract obstruction; Serious pulmonary hypertension; Patients with degree III atrioventricular block or their family members did not agree to participate in the study; Subjects who withdrew from the research program or lost their follow-up.

Design outcomes

Primary

MeasureTime frame
peak oxygen uptake;

Secondary

MeasureTime frame
peak heart rate;maximal metabolic equivalents;maximal respiratory exchange rate;anaerobic threshold oxygen uptake;anaerobic threshold workload;maximal workload;maximal ventilation;maximal O2 pulse;

Countries

China

Contacts

Public ContactFei Yuan

Beijing anzhen hospital affiliated to Capital Medical University

fengyan_zidanna@163.com+86 132 6403 3691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026